DESPOINA GEORGIADOU

Dr. DESPOINA GEORGIADOU

HEMATOLOGY A.FLEMIG DEPARTMENT, Sismanoglio General Hospital, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2002 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
VNViniou N.
Viniou N.
TETerpos E.
Terpos E.
GAGalanopoulos A.
Galanopoulos A.
KEKritikou-Griva E.
Kritikou-Griva E.
ASAkel S.
Akel S.
YXYataganas X.
Yataganas X.

28 February 2008 in Leukemia
Verified
Journal Article
Closed access
CSC Stavropoulou
C Stavropoulou
DESPOINA GEORGIADOUDESPOINA GEORGIADOU
DESPOINA GEORGIADOU
CSC Sambani
C Sambani
HRH Rigana
H Rigana
VGV N Georgakakos
V N Georgakakos
VMV Makropoulos
V Makropoulos

Verified
Journal Article
Open access
PDF file
DESPOINA GEORGIADOUDESPOINA GEORGIADOU
DESPOINA GEORGIADOU
Theodoros XanthosTheodoros Xanthos
Theodoros Xanthos
VKVeroniki Komninaka
Veroniki Komninaka
RXRea Xatzikiriakou
Rea Xatzikiriakou
Stavroula BakaStavroula Baka
Stavroula Baka
NICOLETTA IACOVIDOUNICOLETTA IACOVIDOU
NICOLETTA IACOVIDOU
Background: COVID-19-associated coagulopathy (CAC) is a complex condition, with high rates of thrombosis, high levels of inflammation markers and hypercoagulation (increased levels of fibrinogen and D-Dimer), as well as extensive microthrombosis in the lungs and other organs of the deceased. It resembles, without being identical, other coagulation disorders such as sepsis-DIC (SIC/DIC), hemophagocyte syndrome (HPS) and thrombotic microangiopathy (TMA). Platelets (PLTs), key regulators of thrombosis, inflammation and immunity, are considered an important risk mediator in COVID-19 pathogenesis. Platelet index MPV/PLT ratio is reported in the literature as more specific in the prognosis of platelet-related systemic thrombogenicity. Studies of MPV/PLT ratio with regards to the severity of COVID-19 disease are limited, and there are no references regarding this ratio to the outcome of COVID-19 disease at specific time points of hospitalization. The aim of this study is to evaluate the relationship of COVID-19 mortality with the red cell distribution width–coefficient of variation (RDW-CV), platelets and MPV/PLT ratio parameters. Methods: Values of these parameters in 511 COVID-19 hospitalized patients were recorded (a) on admission, (b) as mean values of the 1st and 2nd week of hospitalization, (c) over the total duration of hospitalization, (d) as nadir and zenith values, and (e) at discharge. Results: As for mortality (survivors vs. deceased), statistical analysis with ROC curves showed that regarding the values of the parameters on admission, only the RDW-CV baseline was of prognostic value. Platelet parameters, absolute number and MPV/PLT ratio had predictive potential for the disease outcome only as 2nd week values. On the contrary, with regards to disease severity (mild/moderate versus severe/critical), only the MPV/PLT ratio on admission can be used for prognosis, and to a moderate degree. On multivariable logistic regression analysis, only the RDW-CV mean hospitalization value (RDW-CV mean) was an independent and prognostic variable for mortality. Regarding disease severity, the MPV/PLT ratio on admission and RDW-CV mean were independent and prognostic variables. Conclusions: RDW-CV, platelets and MPV/PLT ratio hematological parameters could be of predictive value for mortality and severity in COVID-19 disease, depending on the hospitalization timeline.

1 January 1992
Verified
Journal Article
Closed access
NHN A Harhalakis
N A Harhalakis
MAM Alevizaki
M Alevizaki
DESPOINA GEORGIADOUDESPOINA GEORGIADOU
DESPOINA GEORGIADOU
TPT Paraskevopoulou
T Paraskevopoulou
KDK Dai
K Dai
ASA Souvatzoglou
A Souvatzoglou